TGFB1 and metabolic dysfunction-associated steatotic liver disease: The effects above facilitate the production and secretion of pro-inflammatory cytokines IL-6, transforming growth factor-β (TGF-β), and IFN-γ, leading to nonalcoholic fatty liver disease (NAFLD).